IN SEARCH OF LOST TIME:
Can We Finally Have a Pan American Neurology?

J.Eduardo San Esteban, MD

J.Eduardo San Esteban, MD

J.Eduardo San Esteban, MD

From Oct. 29th to Nov. 3rd, 2016, Cancun, Mexico, will host the 14th Pan American Congress of Neurology. This will be the second time for the Pan American Congress to be held in this country. Mexico hosted the fourth Pan American Congress in 1975. There have been more than 50 years of Pan American neurology meetings and maybe the time has come to question ourselves as to whether we have made some progress in this continent in building a real Pan American Neurology and more important, how prepared we are to develop an alliance to help each other in the pursuit of improved care of our patients with neurological illness.

The American continent, with a population of around one billion is marked by inequality in human development. We also have a diversity of geographic, economic, political, and cultural systems. And, of course, we also have different health systems to provide care to an ever more demanding population. The obvious differences between the countries north and south of the Rio Grande have provided the grounds for a multinational effort to increase our cooperation. There are social and economic treaties, cultural and professional agreements, some of them with better results than others, but all of them with the idea of finding an improved quality of life. The cooperation among the Latin American states has been also prolific. Despite some differences, our similarities have prevailed, and in multiple examples we can see the results of intelligent and generous collaborations.

In-Search-of-Lost-Time-posterNeurological disease has increased its burden over the world population. Naturally, the Pan American community is no exception. There are some particular situations in different areas— infectious and parasitic disease are still everyday events in some areas, malnutrition and metabolic in others, children with sequelae of difficult pregnancies and deliveries are prevalent in some communities, but the frequent pathologies of the nervous system are similar in all of our countries. Cerebrovascular disease, epilepsy, neurodegenerative disease, developmental difficulties, headaches, and behavioral syndromes have a very similar prevalence. Increases in communication and migration have also contributed to provide a more universal panorama of illness. And, of course the appearance of new threats like Zika virus has swiftly become a multinational preoccupation.

The neurological community has an ideal opportunity to play a significant part in this continental effort. The southern countries have a common language, a very similar cultural background, and a rather equal social, ethnic, and developmental history. We also have a significant increase in technology and communications that have made distances shorter and real-time interaction an everyday occurrence. The northern countries have developed scientific and technological strength that keep them in the frontier of new knowledge. The advance of educational technological facilities have made teleconferences, telemedicine, online courses, and consultations an everyday event.

The question is: Can we, the neurologists of the American continent, build a professional, scientific, social, and educational alliance to help with the possibilities of improving the care of neurological patients around the continent?

What should we do and what can we do to achieve a situation of true and universal cooperation? A north, south, east, and west alliance can be a reality in the fields of education, epidemiology, interchange of information, online consultations, collaborative studies, and so on.

No doubt, the area of neurological education seems the immediate possible goal. There are already multiple programs ongoing. The traditional journey of Latin American professionals to the United States and Canada for an update in the state-of-the-art of neurology, and programs for the neurological subspecialties are a common-day reality. But the extent of these educational efforts hardly meets the needs of a large population of specialists who do not have the opportunities to travel. Well-planned alliances between countries could help to reduce these gaps. Online education is a useful tool. Teleconferences and meetings, and the distribution of information in accordance with a well-planned program that avoids commercialization of information, are all possible ways of collaboration.

The production of human resources for neurological care is another area where alliances can prove beneficial. Based in carefully performed studies that provide information about needs, a combined program of online and onsite education can help to reduce the lack of the most needed professional and technical resources. Even at the level of pre-graduate students, a multinational effort could address the needs of medical schools for a more complete neurological education. Education of first-contact physicians, family and general practitioners, and even paramedical personnel that provide attention in remote areas can be tackled by such an alliance.

Time is short. Population growth is fast, and new challenges wait for us everyday. Maybe the time has come to stop the search for the lost time and start a true alliance of Pan American countries to improve the health of our people who ail from neurological diseases. Maybe, as multinational independent professionals, with no other aims but to help our patients, we can put forth a special effort to develop such an alliance. Maybe we can have a continental Pan American neurology that can help bring the benefits of science, knowledge, and technology to a large population of patients who do not currently have opportunities to enjoy the same care as others. There are more than 30 countries in our continents united by geographical chance, but with the need to be united by more than that.

The forthcoming Pan American Congress in Cancun could be an opportunity to talk about these themes and ideas, and perhaps come up with an incipient program to help us make up the lost time.

J.Eduardo San Esteban, MD is the educational coordinator and former president of the Mexican Academy of Neurology, and director of education of the Neurology Center, American British Cowdray Hospital, Mexico City.

BOOK REVIEW
Duchenne Muscular Dystrophy, 4th Edition

Alan EH Emery, Francesco Muntoni, and Rosaline Quinlivan
Oxford University Press
271 Pages

John F. Brandsema, MD

John F. Brandsema, MD

In the preface of their 4th edition, the authors recall the necessity of a second edition being published only a year after their first in 1987, due to the isolation and cloning of the dystrophin gene and the identification of its protein product. The subsequent 25 years have seen an explosion of research in both basic science and clinical medicine regarding the biochemical underpinnings and the clinical management of Duchenne muscular dystrophy (DMD), a broad field that is expertly and concisely summarized in the current edition.

This trim (roughly 270 pages plus references) and well-written textbook by a highly respected group of neuromuscular clinicians in England is a pleasure to read. The flow is excellent, with little of the repetitiveness or ambiguity of thought that can occur in multi-author endeavors. There is a fascinating exploration of the history of DMD, from the first depictions of what is believed to be muscular dystrophy in Ancient Egyptian hieroglyphics to acknowledgement by the authors of prominent contemporaries in the field today. Complex concepts and topics regarding the biochemistry and genetics of DMD are conveyed in a concise and clear manner, with supportive data largely drawn from the vast clinical experience of the authors themselves.

Book-review-MuscularDystrophyThere were very few aspects of the book that disappointed me as a reader who specializes in care of pediatric neuromuscular disorders, and none were overly striking. While all figures are interpretable regarding what they are meant to illustrate, many of the pathology figures in particular would be much better appreciated in color rather than the black and white version in the text. A color section of the text or an online color supplement would greatly augment the reader’s appreciation of the beautiful examples selected for presentation regarding the pathology of DMD. The recommendation to perform muscle biopsy in every patient for direct dystrophin studies, in addition to molecular genetics, is somewhat strongly worded for the current practice of most of today’s neuromuscular clinics. However, the authors do temper this by emphasizing in other sections of the text the particular populations where this can be especially useful, such as a young patient with an identified dystrophin gene mutation which has previously been reported as having variable phenotypic expressions. It is also easily appreciated that the multi-systemic management issues in older Duchenne patients are complex: in the text, topics such as spinal surgery and cardiopulmonary management are dealt with rather briefly, in contrast to the more extensive discussion of musculoskeletal management of the ambulant child with DMD, for example. These are all minor points, and none was jarring enough to detract from the book’s many admirable qualities.

Overall, this book is impressive in its scope. The timeliness of any textbook suffers somewhat from the time delay related to its publication schedule, but the discussion of therapeutic trials in this text, addressing both genotypic and phenotypic modification of DMD, nicely introduces most of the concepts still actively being studied today. Another particular strength is the unblinkingly honest and insightful discussion of sensitive topics, such as disclosing a diagnosis of DMD, and psychological problems in boys with DMD and their families. These aspects of DMD management are essential to excellent care, but are less often addressed in scientific publications about DMD.

In summary, I strongly recommend this book as a natural addition to the library of any clinician who specializes in treating neuromuscular disorders, and it would be of interest to anyone who may encounter patients with DMD in their practice, including physical/occupational therapists, nurses, genetic counselors, social workers, dietitians, neurologists, physiatrists, geneticists, cardiologists, pulmonologists, orthopedists, and more. As the field of research related to DMD continues to evolve at a rapid pace, hopefully another edition will soon update discoveries and advances.

Training in Neurology ­– a Future Regular Column in World Neurology

By Wolfgang Grisold, MD, Walter Struhal, MD, and Steven L. Lewis, MD

World Neurology is planning a column in each issue devoted to neurological education. This new feature will help promote educational concepts and also will serve as a platform for new educational ideas and structures.

Neurologic education and education research are of crucial interest to promote high quality neurologic care throughout the world, and is one of the critical roles of the World Federation of Neurology (WFN).

For example, within the current issue and the previous issue, World Neurology has covered “training stories”— individual experiences reflecting an exchange program or a national curriculum. These and similar articles are important contributions for our global readers.

In future issues, we plan to implement a regular column on neurologic education and educational concepts and ideas. We encourage submissions on educational topics, including but not limited to the following:

  • Post-graduate neurologic education
  • Continuing medical education
  • Quality assurance on a national or international level
  • Assessment techniques
  • International harmonization of training projects
  • Advocacy activities to promote neurologic education nationally or internationally
  • Patient education
  • Caregiver education
  • Public education

World Neurology encourages the submission of short articles with a maximum of 750 words, a short summary, a maximum up to five key references, and up to one figure and one table.

World Neurology appears six times a year, is free, and reaches approximately 18,000 readers. Your contribution will have an impact worldwide.

Wolfgang Grisold, Walter Struhal, and Steven L. Lewis will edit this new initiative. We look forward to reviewing your submissions. Submissions should be sent to traininginneurology@wfneurology.org.

World Neurology is encouraging submissions on a variety of topics related to neurologic education, including, but not limited, to education of neurologic trainees, continuing education, and education of the public. Clockwise top, from left to right. Figure 1 shows neurologists in training in Vienna, Austria, figure 2 shows neurologists attending a continuing neurologic education symposium in Almaty, Kazakhstan in August 2015, and figure 3 shows Patient Day at the World Congress of Neurology in Santiago Chile, October 31, 2015.

World Neurology is encouraging submissions on a variety of topics related to neurologic education, including, but not limited, to education of neurologic trainees, continuing education, and education of the public. Clockwise top, from left to right. Figure 1 shows neurologists in training in Vienna, Austria, figure 2 shows neurologists attending a continuing neurologic education symposium in Almaty, Kazakhstan in August 2015, and figure 3 shows Patient Day at the World Congress of Neurology in Santiago Chile, October 31, 2015.

WFN and the German Neurological Society
Department Visit Program

Ralf Gold, MD, Wolfgang Grisold, MD, Albert Ludolph, MD, and Thomas ThiekÖtter, MD

Ralf Gold, MD, Albert Ludolph, MD, and Thomas Thiekötter, MD

Ralf Gold, MD, Albert Ludolph, MD, and Thomas Thiekötter, MD

The World Federation of Neurology (WFN) and the German Neurological Society (DGN) are pleased to announce a new partnership to invite two colleagues from Africa to visit the neurology department of the St. Josef-Hospital in Bochum, Germany, part of the University Hospital of the Ruhr University Bochum and the department of neurology at the Hospital of Ulm University.

Wilhelm Erb initially founded the German Neurological Society (DGN) as the “Gesellschaft Deutscher Nervenärzte” in 1907. In 1935, the society was dissolved by the Nazi government. The re-establishment of the society took place in 1950 by Heinrich Pette. The DGN is part of the Association of the Scientific Medical Societies in Germany (AWMF). The current chairman is Professor Ralf Gold from Bochum. In recent years the DGN has become a fast-growing society, which represents more than 8,000 members.

The WFN was formed in Brussels in 1957 as an association of national neurological societies. Today, the WFN represents 119 professional societies in 118 countries in all regions of the world. WFN’s mission is to foster quality neurology and brain health worldwide, a goal it seeks to achieve by promoting global neurological education and training, with the emphasis placed firmly on under-resourced parts of the world.

About the Project

The German Neurological Society supports the WFN’s African initiative by inviting two African colleagues to visit the department of neurology in the St. Josef-Hospital in Bochum (University Clinic of the Ruhr University) and the department of neurology at the Hospital of Ulm University for four weeks. The purpose of the visit is to experience the German neurological system in an international environment, meet new colleagues, and foster future cooperation.

About the Host Institutions

St. Josef-Hospital, Ruhr University Bochum: The department of neurology at St. Josef-Hospital is part of the University Hospital of the Ruhr University Bochum. The chair of the department is Professor Ralf Gold, who is also the current president of the German Neurological Society. The department comprises a total of 106 beds, including an intensive care unit, an intermediate care unit, and a certified supra-regional stroke unit. Neuroimmunological diseases represent the main clinical and scientific focus. The department of neurology has its own CSF-lab and its own plasma exchange unit. Neurosonology of the central as well as of the peripheral nerve system, constitutes a further focus, and the neurosonology lab is one of the few DEGUM-certified labs in Germany. Cerebrovascular diseases are treated according to the latest state of medicine, including mechanical thrombectomies. Furthermore, there is special expertise in the treatment of neurodegenerative disorders such as Parkinson’s or Huntington’s disease.

The Ruhr University Bochum (RUB) was founded in 1962 as the first new public university in Germany since 1945. Today, the RUB is one of the largest universities in Germany and harbors more than 20 faculties.

University Hospital of Ulm (RKU): The department of neurology, University Hospital of Ulm (RKU), chaired by Professor Albert C. Ludolph, is a maximum care hospital for neurology (tertiary referral) for 93 inpatients, including a certified supra-regional stroke unit/intermediate care ward for 27 inpatients, plus additional beds in an interdisciplinary intensive care unit and an additional neurological rehabilitation clinic with all levels of rehabilitation care. The department of neurology has its own CSF-lab and its own immune adsorption unit. The clinic has a dedicated imaging facility with MRI (where neurologists are specifically trained) and a state-of-the-art angiography unit where mechanical thrombectomies are performed. The outpatient clinic includes multiple, highly specialized outpatient clinics (including those for amyotrophic lateral sclerosis, Huntington´s disease, Parkinson´s disease and other movement disorders, multiple sclerosis, dementias, epilepsy, pain, brain tumors, etc.) and a dedicated neurological clinical study center. The main clinical and scientific focus is motor neuron disorders/amyotrophic lateral sclerosis for which the department is one of the world´s largest and most renowned centers.

The visit will take place in mid-October 2016.

Details about support

The German Neurological Society will provide the following support:

  • Travel expenses: Country of Residence — Germany — Country of Residence
  • Accommodations for four weeks
  • Living expenses (food and beverage) during the four weeks
  • Costs of health insurance during the stay in Germany

Criteria for applications:

  • The applicant must be a resident of a country in a low or lower, middle-income country in the African continent
  • The applicant must have been born after December 12, 1975

Evaluation Committee:

Two representatives of the German Neurological Society

Two representatives of the WFN Education Committee

Two representatives from the African Academy of Neurology

Deadline for application:

To apply, applicants must email their CV, a supporting statement, and a letter of recommendation from their head of department by May 30, 2016 to the WFN Education Coordinator, Ella Nkanagu, enkanagu@kenes.com.

For any questions regarding your application, or to apply, please contact the administrative office of the WFN Education Committee at +41 22 908 0164 or enkanagu@kenes.com.

Ralf Gold, MD, is professor and chair, department of neurology, Ruhr University, Bochum, Germany; Wolfgang Grisold, MD, is WFN secretary general and a professor in the department of neurology, Kaiser Franz Josef Hospital of Vienna, Austria; Albert Ludolph, MD, is chairman, department of neurology, University of Ulm, Germany; and Thomas Thiekötter, MD, is CEO, German Neurological Society, Berlin.

PRESIDENT’S COLUMN:
When Neurology Is Under the Spotlight

Raad Shakir

Raad Shakir

Over the last three months, the world has been facing a most serious and devastating epidemic. The World Health Organization (WHO) declared Zika virus infection as a Public Health Emergency of International Concern (PHEIC). This has triggered a massive international response not only in the Americas, but also across the world. Cases of Zika virus infection are being reported in the thousands across the northern parts of South and Central America. To date, the WHO reports the infection to be present in 62 countries between 2007 and 2016. The transmission is not only reported in Latin America, but in Cape Verde, and recently Vietnam reported mosquito-borne Zika virus infection.

The issue is compounded by the fact that the symptoms of the Zika virus infection are mild, and none disabling. However, the neurological complications are most serious. Zika virus infection is described as the most devastating viral infection during pregnancy. The reported microcephaly is most serious, and we have no idea what the future holds for those babies born to mothers without obvious microcephaly. One can reasonably conclude that the reported Zika virus isolated from post mortem cases of invasion of brain and spinal cord suggests that we may be facing a future group of affected children with many neurological complications of as yet unknown nature.

Figure 2- left to right, Dr. Iledefonso Rodriguez Leyva, Dr. Karina Velez Jimenez, Professor Raad Shakir, Dr. Minerva Lopez, Dr. Steven L. Lewis, during the WFN visit to neurology training programs in Mexico City.

Figure 2- left to right, Dr. Iledefonso Rodriguez Leyva, Dr. Karina Velez Jimenez, Professor Raad Shakir, Dr. Minerva Lopez, Dr. Steven L. Lewis, during the WFN visit to neurology training programs in Mexico City.

The second neurological condition which has increased in those affected with Zika virus infection is Guillain-Barre syndrome. This, in a way, is expected following a viral infection. The seriousness of the condition is made much worse by the lack of local availability of supportive treatment. Generally, at least a fifth of GBS patients may require respiratory support, which is compounded with lack of availability of IV immunoglobulin. The cost of both modalities is prohibitive. In some parts of Latin America, the use of plasma exchange is the way GBS is treated rather than IV immunoglobulin. Even with this, many locations in affected areas do not have the facilities or the training to use plasma exchange machines. This puts lives at risk.

One has to remember that the diagnosis and management of GBS requires neurological expertise, which is scarce to say the least. It would be reasonable to state that the 1 in 20 mortality rate reported in the developed world will be much higher for those affected by GBS in the currently Zika virus affected areas.

All this prompted the WFN to mount a concerted effort to tackle the problem. The WFN Zika Virus Working Group was formed, and the committee is chaired by John England, MD, New Orleans. The membership includes experts in child neurology and GBS, with neurologists from the most affected countries in South and Central America. See more at www.wfneurology.org/committees?tab=16016.

Meeting of the WFN with some of the members of the Zika Working Group at the American Academy of Neurology Annual Meeting in Vancouver on April 18, 2016. From left to right: Raad Shakir, MD; David Bearden MD; Ildefonso Rodriguez-Leyva, MD; Miguel Osorno Guerra, MD; Minerva Lopez Ruiz, MD; Karina Velez Jimenez, MD; Allen Aksamit, MD; and Russell Bartt, MD; Also participating in the meeting, but not in the photo, were William Carroll, MD, Wolfgang Grisold, MD, Steven Lewis, MD, and Marco T. Medina, MD.

Meeting of the WFN with some of the members of the Zika Working Group at the American Academy of Neurology Annual Meeting April 18 in Vancouver. From left to right: Raad Shakir, MD; David Bearden MD; Ildefonso Rodriguez-Leyva, MD; Miguel Osorno Guerra, MD; Minerva Lopez Ruiz, MD; Karina Velez Jimenez, MD; Allen Aksamit, MD; and Russell Bartt, MD; Also participating in the meeting, but not in the photo, were William Carroll, MD, Wolfgang Grisold, MD, Steven Lewis, MD, and Marco T. Medina, MD.

Meeting of the WFN with some of the members of the Zika Working Group at the American Academy of Neurology Annual Meeting April 18 in Vancouver. Meeting of the WFN with some of the members of the Zika Working Group at the American Academy of Neurology Annual Meeting April 18 in Vancouver.

The WFN is also an active contributor to the WHO committee on Zika. This committee met in Geneva, and according to Dr. England’s executive summary, “Collaborative interdisciplinary research on Zika infection and its neurological complications is already being organized, but funding is severely lacking at this time. As an important first step to enhance research collaboration and provide for transparent data sharing, the Neurovirus Emerging in the Americas Study (NEAS), www.neasstudy.org/en/home/, is being organized and is supported by an approved Johns Hopkins Medical Institutions IRB protocol. Researchers are encouraged to visit the NEAS website for additional information. The situation is rapidly evolving; therefore, all information is subject to modification as we learn more about this emerging crisis.”

The WHO situation report on April 7, 2016 concludes “The global prevention and control strategy launched by the World Health Organization (WHO) as a Strategic Response Framework encompasses surveillance, response activities, and research. This situation report is organized under those headings.”

The WFN Zika virus committee met on Monday, April 18th in Vancouver during the 68th AAN meeting to further discuss the issues. The following questions were put to the experts for a response.

  1. Do we have a diagnostic ELISA test or the like, for quick diagnosis?
  2. Can individuals have the neurological complications without exhibiting the febrile illness, and if so how can we be sure of diagnosis?
  3. Do we know the spectrum of all the fetal neurological deficits?
  4. How long is the period of viral human-to-human infectivity after the Zika virus infection illness?
  5. Do we have a registry of morbidity and mortality related to GBS resulting from Zika virus infection?
  6. It is important to understand whether the variant of GBS associated with Zika is different than other varieties of GBS.
  7. Is there a registry of cases of neurological Zika virus infection other than GBS?
  8. Any report on vaccine development?
  9. Is Zika virus present in breast milk and what is the risk to breast-fed infants?
Pres-Column-Fig1_NeurologyAtlas_1

Legend Fig. 1 Neurology Atlas 2015. Editor’s note: The data in the Neurology Atlas figure are a draft and the definitive data may be different when the final WHO version is produced.

One can easily see that the brunt of the neurological complications fall in the child neurology world. The WFN is working very closely with the International Child Neurology Association to collaborate and come up with a joint stance in combating this most devastating viral infection during pregnancy. The ICNA is dedicating a session of its forthcoming world congress to Zika viral infection.

The division of mental health, substance abuse, and neurosciences in the WHO is very keen on informing member states on the importance of neurological expertise in the fight against Zika virus infection. This has brought into focus the dire lack of neurologists both for adults and children across the world. The second edition of the Neurology Atlas jointly produced by the WHO and the WFN has demonstrated in its figures that the mean number of neurologists per 100,000 people is 0.7 in the Americas, compared to 6.6 in Europe (Fig1). The figures are more poignant as the Pan American region includes the U.S. and Canada. The logical conclusion is that there is a vast shortage in the areas affected by Zika virus infection.

The WFN is collaborating with the Canadian Neurological Society to join the worldwide program for short-term training of young neurologists and in this case neurologists will be chosen from Latin America for short training periods in Canada. The WFN has already had such a program with four European countries for training African Neurologists, and now the program is branching out to the Americas.

In March 2016, the neurology training program in Mexico has been inspected and accredited by the WFN, and a similar short-term training will start. Mexico already trains young neurologists from across Central America (Fig2).

Perhaps Zika virus infection has produced a momentum for all of us to demonstrate our willingness to cooperate and act quickly in the face of this pandemic. We are at the beginning of a long, difficult, and tortuous road.

World Brain Day 2016

Brain Health in an Aging Population: “The Aging Brain”
By Mohammad Wasay, MD, FRCP, FAAN, and Wolfgang Grisold, MD

An Aging Population

World-Brain-Day-imageThe global share of older people (age 60 and over) is more than 800 million (12 percent of the population) and is growing, with the expectation that it will reach more than two billion (21 percent of the population) by 2050. Currently 70 percent of the world’s older population lives in developed and developing countries, but by 2025, 80 percent of the older population will be living in less developed countries. Older persons are projected to exceed the number of children in 2047. It has already started in developed countries. In 2015, Japan became the first country in the world where more adult diapers than baby diapers were sold.

Population aging has major social, health, and economic consequences. The prevalence of non-communicable diseases and disability increases with age. Poverty is high among older persons. There is increased pressure on social support systems for older persons. The growing burden of diseases and disability, and reducing financial and social support in an aging population will be among the huge challenges for societies and governments with respect to their social and health care systems in coming years.

Brain Diseases in the Aging Population

The prevalence of a number of neurological diseases increases with age, including stroke, dementia, and Parkinson’s disease. It is estimated that 10 to 20 percent of people aged 60 to 80 years suffer from one or more of these diseases. More than 30 percent of persons who are 80 years or older suffer from at least one neurological disease.

Disability due to neurological diseases and other musculoskeletal diseases is very high and growing. It is estimated that more than 20 percent of people over 60 years old need support for activities of daily living.

The economic burden of this is huge. It is estimated that almost half of the health care expenditure is related to the care of older persons in developed countries today, and it is projected to become two-thirds by 2030. The same trends are expected in developing and less developed countries by 2050.

The medical community, however, must be cautious on the wording when “burden” with regards to costs of the aging populations is mentioned. We need to be aware that the word “burden” has a potentially negative connotation, which rather should be replaced with a more positive wording— which we feel is better stated as a responsibility.

World Brain Day Theme: “Brain Health in an Aging Population”

It is clear that brain health is going to be the most important determinant of social and economic well being of older persons in the future. On the one hand, health care authorities are deeply concerned with the current status and future trends of our growing population, but little has been done to handle these growing needs.

The World Federation of Neurology has stepped forward to dedicate this year’s World Brain Day to the aging population and has chosen the motto: “The aging brain.” Our intention for this World Brain Day is to increase awareness about the treatment and prevention of brain and neuromuscular diseases affecting mostly elderly persons. The first step of prevention is to improve concepts and means of brain health also among the younger population in order to help prevent brain disease later in life and to improve the quality of life for older persons.

Disease prevention is the concept. However, a much larger number of individuals will be affected by diseases of the brain and the neuromuscular system, which are not (yet) preventable. Thus it is also the duty of society to care for the elderly with progressed neurological disease, and to provide the framework for quality of life, dignity, and the necessary care.

In this group of patients, the focus has to shift from the aspect of a curative condition, towards the inevitable death of all individuals. The concept of palliative care and hospice needs to be implemented in the aging population and in neurological care.

How Can we Improve Brain Health and Prevent or Treat Neurologic Diseases and Care for Persons with Advanced Brain Disease?

Stroke and vascular dementia are among the most important neurological diseases affecting persons of higher age. For these conditions, there are preventable and modifiable risk factors. Education, cognitive exercises, physical activity, and nutrition are important areas of intervention for prevention and slowing down of cognitive decline. Parkinson’s disease is a neurodegenerative disorder, but effective symptomatic treatment is available.

Emotional health is as important as cognitive health in elderly persons. Quality of life and a lack of disability can be associated with emotional well-being. Effective interventions are available for maintenance and promotion of emotional health.

Despite prevention strategies, age is a non-modifiable risk factor, just as effects of degenerative and hereditary diseases on the brain and the neuromuscular system. Supportive, palliative care, and the hospice concept need to be integrated into the concept of neurological care in dealing with an aging population.

WFN and National Societies Activities

To raise awareness with respect to the aging brain and neurologic diseases in the elderly, the WFN is asking its members to use this year‘s “Day of the Brain” to advocate and campaign in their country for these emerging problems.

The WFN public awareness and advocacy committee will prepare publicity material for this campaign, which includes logos, banner ads for web sites, handbills, brochures, posters, billboards, and presentations.

There will be a press conference. A template press release will be prepared and circulated to delegate societies. They can be adapted for local use with respect to national/regional data, priorities, or by adding quotes from national/regional experts.

The most important target of this campaign is the public. We need to create simple messages in local languages and promote them via print, electronic and social media, billboards, banner, events, etc.

Other important areas of intervention are health care authorities and policy makers. Our campaign should result in policy and priority shift at the national or local level. We have to plan targeted activities to facilitate this outcome.

Another important area of intervention is awareness and training of general practitioners, nurses, and paramedical staff.

Involvement of the media is a must. Celebrities or scientists could be a part of this advocacy campaign.

Delegate societies are strongly encouraged to organize awareness activities that may include press conferences, media briefing sessions involving local media, seminars, conferences, public awareness sessions, presentations at local schools, colleges, universities, posters, essays, drawing competitions, and newspaper and magazine articles.

Collaborators

As in the past, the WFN will work with various health entities, and professional and welfare organizations to promote awareness for World Brain Day.

The WFN is hoping for your collaboration to improve the health and future of patients with an aging brain. Please follow our website, www.worldneurologyonline.com and our social media. If you have suggestions, or ideas for World Brain Day 2017, please do not hesitate to contact us at wbd2016@wfneurology.org.

 

 

From The Editors

By Steven L. Lewis, MD, Editor, and Walter Struhal, MD, Co-Editor

Walter Struhal

Walter Struhal

STEVEN L. LEWIS

Steven L. Lewis

We are pleased to introduce this issue of World Neurology, which includes topics of interest to all readers. In this issue, Raad Shakir, MD, the president of the WFN, reports on the work being done to address the Zika virus epidemic, including efforts via the World Health Organization (WHO) and the WFN. Mamta Bhushan Singh, MD, and Michael F Finkel, MD, discuss the challenges and issues involved in tackling the problem of epilepsy in the developing world. Mohammad Wasay, MD, and Professor Wolfgang Grisold, MD, the secretary-general of the WFN, review the background and planning for this year’s day of the brain, World Brain Day 2016: Brain Health in an Aging Population. J. Eduardo San Esteban, MD, discusses the past, present, and hopes for the future of Pan American neurology and collaboration to address neurological diseases throughout the Americas. Also in this issue, Morris Freedman, MD, trustee of the WFN, with colleagues from the WFN and the Canadian Neurological Society, announce a new joint initiative between our two organizations for neurology trainees or junior faculty from Central or South America to visit the Montreal Neurological Institute for a four-week department visit. Similarly, in this issue, the WFN and the German Neurological Society announce a new department visit program for two African colleagues to visit the department of neurology in the St. Josef-Hospital in Bochum (University Clinic of the Ruhr University) and the department of neurology at the Hospital of Ulm University for four weeks. As an example of the outcome from such a visit, Kalpesh Deraji Jivan, MD, from South Africa writes an enthusiastic report from his four-week visit to the neurology intensive care unit at Innsbruck Medical University in Austria, sponsored by the WFN and the Austrian Neurological Society. Vera Bril, MD, discusses the plans for the upcoming 14th International Congress on Neuromuscular Diseases being held in collaboration with the WFN in July 2016 in Toronto. Finally, in our regular columns, John D. England, MD, editor-in-chief of the Journal of the Neurological Sciences, provides his editor’s update and selected free-access articles from the two most recent issues of the journal; John F. Brandsema, MD, reviews a recent book on Duchenne muscular dystrophy; and M. J. Eadie, MD, provides a biography of a pioneer in the epidemiology of multiple sclerosis.

We hope you enjoy reading this issue of World Neurology. Within this issue, Dr. Grisold and the editors also announce a call for articles on neurologic education for future issues. We look forward to these and other submissions of interest to the readers of World Neurology.

14th International Congress on Neuromuscular Diseases to Feature the World’s Leading Experts

By Vera Bril, MD

VERA BRIL, MD

VERA BRIL, MD

The 14th International Congress on Neuromuscular Diseases (ICNMD 2016), under the auspices of the World Federation of Neurology, will be held in Toronto, Canada from July 5–9, 2016 at the Sheraton Centre Toronto Hotel. The ICNMD is the formal meeting of the Research Group on Neuromuscular Diseases, formally affiliated with the World Federation of Neurology. It has been 14 years since the ICNMD Congress was held in Canada, with Vancouver, British Columbia, hosting the 2002 Congress.

Building on the success of preceding Congresses, in Vancouver, Istanbul, and Naples, it was decided at the previous meeting in Nice, France (ICNMD 2014) that the Congress be moved to a two-year cycle instead of meeting every four years.

While much encouragement and progress is going on in the field of neuromuscular diseases, especially with the recent support of the ALS Ice Bucket Challenge, the disease remains a huge global health problem.

The Congress will address all aspects from muscular dystrophies, other myopathies, myasthenia gravis, polyneuropathies, spinal cord disorders, and neurofibromatosis, to name just a few of the major themes within the Congress. The Congress will include updates on understanding of the genetics, pathogenesis, evaluation, and treatment of neuromuscular disorders.

The Scientific and Program Committee invited some of the world’s leading experts in the field of neuromuscular diseases, with the hope that at the end of the Congress, attendees will have garnered the most up-to-date information available in neuromuscular disorders.

The Congress is CME Accredited from the University of Toronto. For the total number of credits, please visit the Congress website.

The Program and Scientific Committee has worked tirelessly to plan an exemplary and intellectual program to inspire, educate, and support those individuals and organizations that fight against neuromuscular diseases.

The Congress will unofficially start on Tuesday, July 5 with a full day of Teaching Courses. These courses will be small classroom-sized sessions with a focus on the practical applications and knowledge of specific topics.

An Opening Ceremony is scheduled for Tuesday evening, and from Wednesday, July 6 to Saturday, July 9, the Congress will host workshops that offer multidisciplinary exploration of focused topics related to neuromuscular diseases.

There will be four exciting Plenary Sessions that will feature experts in their fields. Topics include genetics, hot topics, muscular dystrophy, and motor neuron disease.

Toronto is one of the most multicultural diverse cities in the world, where more than 140 languages are spoken, and microcosms of different cultures are thriving in unique cohesion. Only a short distance to world renowned attractions like Niagara Falls and the Canadian wilderness, ICNMD 2016 promises to be a highly rewarding meeting on a social and intellectual basis.

For more details around the scientific program, and registration, please visit the Congress website at http://icnmd2016.org. 

Vera Bril, MD, is president of the 14th International Congress on Neuromuscular Diseases (ICNMD) 2016, professor of neurology, Krembil Family chair in neurology, program medical director, Krembil Neuroscience Program, University Health Network, head of neurology, University Health Network, Mt. Sinai Hospital, deputy physician-in-chief, finance, University Health Network, Mt. Sinai Hospital, Toronto.

 

Neurology International Residents Videoconference and Exchange (NIRVE) Connects Neurology Residents Around the World

By Meah Mingyang Gao, MD; Russell Rasquinha, MD, MASc; Manav V. Vyas, MBBS, MSc; Mary Jane Lim Fat, MD; Yuri Kiryanov, MD; Clecio Godeiro, MD, PhD; Fernando Morgadinho Coelho, MD, PhD; Dalia Rotstein, MD, MPH, FRCPC; Tim Patterson; and Morris Freedman, MD, FRCP

A screenshot of NIRVE rounds in September 2015 — First round for the new cycle (2015-16) where all sites introduce themselves. Top left: Slides being presented at the NIRVE rounds from Toronto. Top right: Trainees and staff at Ufa, Russia; and below, trainees and staff at St Petersburg, Russia. Bottom left: Natal, Brazil, and Sà£o Paulo, Brazil.

A screenshot of NIRVE rounds in September 2015 — First round for the new cycle (2015-16) where all sites introduce themselves. Top left: Slides being presented at the NIRVE rounds from Toronto. Top right: Trainees and staff at Ufa, Russia; and below, trainees and staff at St Petersburg, Russia. Bottom left: Natal, Brazil, and Sà£o Paulo, Brazil.

The 2013 WFN neurology training survey highlighted great variability in neurology training programs across the world.1 Neurology trainees are interested in international clinical experiences, but are often constrained by limited flexible time as well as financial, educational or logistical support.2 With the advent of modern technology, 95 percent of current international neurology trainees have reliable Internet access.1 Video-conferenced medical rounds are a new and proven way to supplement medical education across distances and may represent a sustainable solution to global peer learning.3,4

The Neurology International Residents Videoconference and Exchange (NIRVE) is a resident initiative sponsored by the Peter A. Silverman Global e-Health Program, the Canada International Scientific Exchange Program (CISEPO) and the Baycrest Center for Geriatric Care in Toronto. In 2009, Dr. Dalia Rotstein, a former neurology resident and now faculty member at the University of Toronto, established NIRVE with the vision to connect neurology residents across various geographical sites. NIRVE was modeled on the International Behavioral Neurology Videoconference Rounds.5

Figure 1. 61 distinct round topics (main case and image challenge) at 45 NIRVE rounds

Figure 1. 61 distinct round topics (main case and image challenge) at 45 NIRVE rounds

NIRVE was designed to develop leadership skills and create opportunities for residents at all levels to participate in medical education and peer learning, raise awareness of global health concepts in neurology, increase resident advocacy of global health issues, enhance international and national collaboration among neurology residents and act as a gateway for organizing on-site exchanges.

The participating international sites on a rotating basis host the rounds every first Thursday morning of the month. Residents from the host site present a neurology case through videoconferencing technologies, and neurology resident moderators encourage the audience to actively engage in discussions and exchange opinions in real time.

Since its inception, NIRVE has continued to grow and expand. Neurology residents, fellows and faculty from Toronto with international contacts or affiliations initially recruited partner sites. For example, Olga Finlayson, a former University of Toronto neurology resident, helped establish a lasting collaboration and later clinical exchange with the First State Pavlov University in St. Petersburg, Russia. Our current partner sites include Natal, Brazil; Sà£o Paulo, Brazil; Grenoble, France; Jos, Nigeria; and Ufa, Russia. Participation is free and any site in the world with videoconference technology is welcome to join NIRVE as an equal partner.

Methods

Table 1. Results for educational value of NIRVE rounds in 2015 (N = 25)

Table 1. Results for educational value of NIRVE rounds in 2015 (N = 25)

The rounds start at 8 a.m. Eastern time, with a 30-minute case presentation and a 15-minute “image challenge” focused on a radiological or pathological diagnosis, with accompanying neuro-images. The rounds include sufficient time to engage residents in discussions involving diagnostic steps and therapeutic management across the different international sites. The current video-conferencing equipment (H.323/SIP connection protocol) is free within Ontario. International sites connect through a video conference MCU or bridge (Resolve Collaboration) at an hourly rate of slightly more than $35 per site (sponsored by the Peter A. Silverman Global e-Health Program, CISEPO and Baycrest Center for Geriatric Care).5 As of 2015, webcasting with password protection has been implemented using the Ontario Telemedicine Network, allowing any resident with Internet to connect to our rounds.6

As a resident-led initiative, NIRVE values all input from its participants and actively seeks feedback to further improve the program and curriculum to cater to participant needs. In 2015, a formal survey was distributed to all NIRVE participants and site directors from 2014-2015. The questionnaire consisted of four parts: demographic information, questions on the main case presentation, questions on the image challenge and exchange participation. The survey assessed both qualitative and quantitative responses from the participants and was administered using Survey Monkey®.

Results

More than 100 trainees from 10 different sites have attended NIRVE rounds since its inception. Figure 1 shows the categories and number of presentations in each category that have been covered at the NIRVE rounds, with neurovascular and neuroinfectious diseases being the two most common.

Twenty-seven, or 60 percent, of the 45 trainees across four different sites participated in the survey. The average age of these trainees between the ages of 24 to 53 was 29.4 years, and 16, or 60 percent of trainees, were females. While most were neurology residents at different levels of training, two  sub-specialty fellows, one postdoctoral fellow and two PhD students also participated in the survey. Slightly more than 66 percent of trainees identified languages other than English as the language of instruction in their medical training. Of the 25 residents surveyed, 91.6 percent thought that the rounds were relevant to their level of training, 95.8 percent identified that the rounds contributed to their existing knowledge and 87.5 percent agreed that the topics align with their academic interests (Table 1). Seventy-two percent of trainees were interested in presenting at the rounds in the future, and 80 percent indicated an interest in participating in a future clinical exchange program. Most trainees identified the case discussions as the most beneficial aspect of the rounds and suggestions were made to increase emphasis on global health topics and comparing and contrasting practices across the world.

Discussion

There are considerable variations in the occurrence and management of neurological conditions across the world. As neurology trainees prepare for their future careers in an increasingly globalized world, providing early exposure to a variety of cases and management strategies can be challenging. NIRVE provides an opportunity to fill this gap while fostering a platform for potential collaborations.

Over the past years, NIRVE has encountered considerable challenges limiting its expansion. The difference in time zones across countries, various costs associated with room rental and equipment purchase for some international sites, and English as the main language for the rounds have limited the number of trainees we have been able to engage. Looking to the future, creating a bigger role for webcasting, and password-protected archived webcasts could be a more cost-effective strategy to expand our reach. However, increased connectivity may come at the price of reduced real-time interaction. Finally, an on-site clinical exchange is planned for May 2016 in Toronto, including participants from Brazil, Canada and Russia.

Conclusion

Despite challenges including technological, logistical and language-related constraints, NIRVE rounds continue to supplement resident learning across different geographical, political and cultural backgrounds. We welcome residents and fellows from other programs to contact us at nirve.utoronto@gmail.com for more information about NIRVE or to participate in NIRVE. We are happy to provide further information on some technical requirements and further details.

References

  1. Steck A, Struhal W, Sergay SM, Grisold W and the Education Committee World Federation of Neurology. The global perspective on neurology training: the World Federation of Neurology survey. J Neurol Sci. 2013; 334(1-2):30-47
  2. Lyons JL, Coleman ME, Engstrom JW, Mateen FJ. International electives in neurology training: a survey of US and Canadian program directors. Neurology. 2014; 82(2): 119-25
  3. Ali J, Sorvari A, Camera S, Kinach M, Mohammed S, Pandya A. Telemedicine as a potential medium for teaching the Advanced Trauma Life Support (ATLS) course. Journal of Surgical Education. 2013; 70(2): 258-264
  4. Ricci MA, Caputo MP, Callas PW, and Gagne M. The use of Telemedicine for delivering continuing medical education in rural communities. Telemedicine and e-Health. 2005; 11(2): 124-129
  5. Patterson T, Gouider R and Freedman M. Canada, Tunisia Link up for Long Distance Education. World Neurology. 2012; 27(1): 8
  6. Brown EM. The Ontario Telemedicine Network: a case report. Telemed J E Health. 2013; 19(5):373-6
Meah Mingyang Gao, Russell Rasquina, Manav V. Vyas, Mary Jane Lim Fat and Dalia Rotstein are with the division of neurology, department of medicine, University of Toronto. Yuri Kiryanov is with the department of neurology, First Saint-Petersburg Pavlov State Medical University, St Petersburg, Russia. Clecio Godeiro is with the department of neurology, Universidade Federal do Rio Grande do Norte, Natal, Brazil. Fernando Morgadinho Coelho is with the department of neurology, Universidade Federal De Sà£o Paulo, Sà£o Paulo, Brazil. Tim Patterson is with the department of telehealth, Baycrest, Toronto, Canada. Morris Freedman is with the department of medicine, division of neurology, Baycrest Health Sciences, Mt. Sinai Hospital, and University of Toronto; Sam and Ida Ross Memory Clinic, Baycrest; Rotman Research Institute, Baycrest, Toronto, Canada.

 

 

The Norwegian Year of the Brain

By Anne Hege Aamodt, Espen Dietrichs and Hanne Flinstad Harbo

Anne Hege Aamodt (left) and Hanne F. Harbo introducing the program at the closing ceremony for the Norwegian YotB2015

Anne Hege Aamodt (left) and Hanne F. Harbo introducing the program at the closing ceremony for the Norwegian YotB2015

After an invitation from the European Brain Council, we arranged the Norwegian Year of the Brain in 2015 (YotB2015) – 20 years after the first Year of the Brain in Norway. The Norwegian Neurological Association, the Norwegian Brain Council and Nansen Neuroscience Network coordinated YotB2015 and took the initiative to organize different events and activities. The main goals of YotB2015 were to increase the focus on knowledge and research on brain diseases that would lead to improved prevention, treatment and patient care.

Professor Espen Dietrichs, Norwegian delegate to the WFN presenting one of many lectures during the Norwegian YotB2015.

Professor Espen Dietrichs, Norwegian delegate to the WFN presenting one of many lectures during the Norwegian YotB2015.

Upon establishing a national committee in 2014, we exchanged ideas and distributed tasks to stimulate the arrangement of events, media reach and interest-based political work. Many neurological departments, patient organizations, professional organizations and research networks announced the Norwegian Year of the Brain, scheduling activities and events around the country.

The formal opening ceremony was held in February 2015 in the Assembly Hall at the University of Oslo. State Secretary Anne Grethe Erlandsen from the Ministry of Health and Care Service opened the meeting before President Raad Shakir of the WFN, Mary Baker, past president of the European Brain Council, and several Norwegian health leaders, neuroscientists and patients held their lectures and talks.

YotB2015 meeting about treatment of neurological disorders, Oslo University Hospital.

YotB2015 meeting about treatment of neurological disorders, Oslo University Hospital.

Through the year, more than 60 meetings open to the public were held around the country, including lectures and discussions on different perspectives on neuroscience at hospitals, cultural centres and libraries. In Molde, Norway, YotB2015 meetings were part of an international literature festival. And in Oslo, several large meetings on various neuro-related topics were held, including “Literature and the Brain,” “Music and the Brain” and “Food and the Brain.” In addition, there were multiple professional meetings to market the YotB2015 logo, including the 27th National Neurological Congress, the Spring Meeting in the Norwegian Neurological Association, meetings within the Norwegian Academy of Science and Letters and the 1st National Meeting on Endovascular Intervention in Acute Stroke. YotB2015 was also marketed in a stroke campaign. A popular science book about the brain was published by the Norwegian delegate to the WFN, Espen Dietrichs, one of the initiators of both YotB1995 and YotB2015.

From left to right: Brain musicians Kristoffer Lo, John Pà¥l Inderberg and Henning Sommerro; Director of the National Health Directorate Bjørn Guldvog; State Secretary Anne Grethe Erlandsen from the Ministry of Health and Care Service and the Nobel Laureate Edvard Moser together with Hanne Harbo from the Norwegian Brain Council. (Photo courtesy: Norwegian Brain Council.)

From left to right: Brain musicians Kristoffer Lo, John Pà¥l Inderberg and Henning Sommerro; Director of the National Health Directorate Bjørn Guldvog; State Secretary Anne Grethe Erlandsen from the Ministry of Health and Care Service and the Nobel Laureate Edvard Moser together with Hanne Harbo from the Norwegian Brain Council. (Photo courtesy: Norwegian Brain Council.)

During the YotB2015, many neurological topics and challenges were presented in mass media with numerous interviews on TV, radio and newspapers. Information on coming events was continuously updated on the website of the Norwegian Neurological Association and the Norwegian Brain Council. Information was also conveyed through social media platforms, Twitter and Facebook. During the fall, the Norwegian Brain Council also arranged a Facebook campaign called “With a Heart for the Brain,” which generated more than 1 million likes.

Norwegian-Stein

Ragnar Stien, one of the initiators of the Norwegian YotB in both 1995 and 2015, and the audience in Domus Academica at the University of Oslo at the meeting “The Literature and the Brain.”

Erlandsen led December’s closing ceremony. The Director of the National Health Directorate and Nobel laureate Edvard Moser held inspiring lectures on the impact of neuroscience and brain disorders. In addition, so-called “brain music” that was specially composed for the Nobel Prize Award Ceremony in 2014 by two music professors at the Norwegian University of Science and Technology, was presented live for the first time during the closing ceremony.

From left to right: Anne Hege Aamodt, president of Norwegian Neurological Association; Olga Bobrovnikova, renowned pianist battling MS and European Brain Council ambassador; Raad Shakir, WFN president; and Hanne F. Harbo, head of the Norwegian Brain Council. (Photo courtesy: Lise Johannessen Norwegian Medical Society.)

From left to right: Anne Hege Aamodt, president of Norwegian Neurological Association; Olga Bobrovnikova, renowned pianist battling MS and European Brain Council ambassador; Raad Shakir, WFN president; and Hanne F. Harbo, head of the Norwegian Brain Council. (Photo courtesy: Lise Johannessen Norwegian Medical Society.)

We have been working continuously to strengthen the priority area of brain diseases and neuroscience. The Year of the Brain and the neuro field were discussed in the Norwegian Parliament during 2015. We have also had an audience at the health minister and discussed the focus on brain disorders. The Norwegian Brain Council also received a separate post in the fiscal budget for 2016. During the closing ceremony, the state secretary declared that the Ministry of Health and Care Service will make a status report for brain disorders. A few days later, the Health Committee in the Norwegian Parliament underscored the need for a national plan on brain health in Norway.

The Norwegian YotB2015 has resulted in increased interest and knowledge on neurological disorders. Our message that one in three will experience brain disorders and that the neuro field needs to be prioritized stronger has sparked interest. We have achieved political understanding for brain disorders as a focus area and will work further with this issue. We will follow up the announced status report, which should result in a National Brain Plan.

Anne Hege Aamodt is president of the Norwegian Neurological Association, Espen Dietrichs, is a Norwegian delegate to the WFN and Hanne Flinstad Harbo is a leader of the Norwegian Brain Council.